Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A general approach for retrosynthetic molecular core analysis.

Journal of cheminformatics·2021
Same author

Activity landscape image analysis using convolutional neural networks.

Journal of cheminformatics·2021
Same author

Assessing the information content of structural and protein-ligand interaction representations for the classification of kinase inhibitor binding modes via machine learning and active learning.

Journal of cheminformatics·2021
Same author

Informatics for Chemistry, Biology, and Biomedical Sciences.

Journal of chemical information and modeling·2020
Same author

Memory-assisted reinforcement learning for diverse molecular de novo design.

Journal of cheminformatics·2020
Same author

Analysis of Biological Screening Compounds with Single- or Multi-Target Activity via Diagnostic Machine Learning.

Biomolecules·2020
Same journal

From Pixels to Patterns: A Multidimensional Framework to Decode Cytoskeletal Organization.

Computational and structural biotechnology journal·2026
Same journal

A Large Concept Model for Mechanistic Simulation of Disease Trajectories: A Hypothesis-Generating Exemplar for Pediatric Acute Lymphoblastic Leukemia.

Computational and structural biotechnology journal·2026
Same journal

Adversarial Sequence Mutations in AlphaFold and ESMFold Reveal Nonphysical Structural Invariance, Confidence Failures, and Concerns for Protein Design.

Computational and structural biotechnology journal·2026
Same journal

High-Throughput Prediction of Protein-Protein Interactions Uncovers Hidden Molecular Networks in Biosynthetic Gene Clusters.

Computational and structural biotechnology journal·2026
Same journal

A Region-Aware Structured Framework Improves Prediction of Gene Expression from DNA Methylation.

Computational and structural biotechnology journal·2026
Same journal

Ensemble Machine Learning Approaches Predict Survival in Lower-Grade Glioma Based on Glycosphingolipid Gene Expression and Metabolic Modeling.

Computational and structural biotechnology journal·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K

Exploring compound promiscuity patterns and multi-target activity spaces.

Ye Hu1, Disha Gupta-Ostermann1, Jürgen Bajorath2

  • 1Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstr. 2, D-53113 Bonn, Germany ; These authors contributed equally to this work.

Computational and Structural Biotechnology Journal
|April 2, 2014
PubMed
Summary
This summary is machine-generated.

Compound promiscuity, the specific interaction of small molecules with multiple targets, is key to polypharmacology in drug discovery. This review examines recent studies and computational methods for understanding multi-target compound activity.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K
Mapping Dysfunctional Protein-Protein Interactions in Disease
09:39

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

1.1K

Related Experiment Videos

Last Updated: May 1, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.5K
Mapping Dysfunctional Protein-Protein Interactions in Disease
09:39

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

1.1K

Area of Science:

  • Chemical Biology
  • Pharmacology
  • Computational Chemistry

Background:

  • Compound promiscuity, defined as specific interactions with multiple biological targets, underlies polypharmacology.
  • Polypharmacology is an emerging and significant theme in modern drug discovery and chemical biology.
  • Understanding compound promiscuity is crucial for developing effective multi-target therapies.

Purpose of the Study:

  • To review recent studies detailing the extent of promiscuity across various small molecule categories.
  • To discuss a computational approach for navigating multi-target activity spaces.
  • To provide insights into the molecular basis of polypharmacology.

Main Methods:

  • Literature review of recent studies on compound promiscuity.
  • Analysis of small molecule interactions with diverse biological targets.
  • Discussion of a computational strategy for mapping multi-target compound activity.

Main Results:

  • Recent studies offer a detailed understanding of promiscuity levels in different compound classes.
  • An exemplary computational method is presented for exploring multi-target activity landscapes.
  • The review highlights the specific, rather than non-specific, nature of target interactions.

Conclusions:

  • Compound promiscuity is a well-defined phenomenon crucial for polypharmacology.
  • Computational approaches are valuable tools for dissecting complex multi-target interactions.
  • Further research into compound promiscuity will advance drug discovery and chemical biology.